Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VZ3D
|
|||
| Former ID |
DIB013326
|
|||
| Drug Name |
AQ-RA-741
|
|||
| Synonyms |
AQ-RA 741; 123548-16-3; AQ-RA-741; 11-[[4-[4-(DIETHYLAMINO)BUTYL]-1-PIPERIDINYL]ACETYL]-5,11-DIHYDRO-6H-PYRIDO[2,3-B][1,4]BENZODIAZEPIN-6-ONE; 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one,11-[2-[4-[4-(diethylamino)butyl]-1-piperidinyl]acetyl]-5,11-dihydro-; 11-(2-(4-(4-(Diethylamino)butyl)piperidin-1-yl)acetyl)-5H-benzo[e]pyrido[3,2-b][1,4]diazepin-6(11H)-one; 11-((4-(4-(Diethylamino)butyl)-1-piperidinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one; BCUGCHZRMKTPMU-UHFFFAOYSA-N; AC1L2WKT; ACMC-20ej93
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99] | Terminated | [1], [2] | |
| Company |
Dr Karl Thomae GmbH
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H37N5O2
|
|||
| Canonical SMILES |
CCN(CC)CCCCC1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4
|
|||
| InChI |
1S/C27H37N5O2/c1-3-30(4-2)17-8-7-10-21-14-18-31(19-15-21)20-25(33)32-24-13-6-5-11-22(24)27(34)29-23-12-9-16-28-26(23)32/h5-6,9,11-13,16,21H,3-4,7-8,10,14-15,17-20H2,1-2H3,(H,29,34)
|
|||
| InChIKey |
BCUGCHZRMKTPMU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 123548-16-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10242493, 12014256, 14907179, 26753266, 29308690, 47510065, 48105189, 57343231, 78254277, 85788187, 91746621, 103223257, 104371738, 126436783, 127496880, 131342474, 135084946, 135698248, 162023254, 162312721, 162781867, 172657834, 179149727, 184538649, 196372351, 204380143, 215779624, 223554803, 224953712, 233158255, 252156418, 252166785, 252325817
|
|||
| ChEBI ID |
CHEBI:93432
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8584). | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002261) | |||
| REF 3 | Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle. Eur J Pharmacol. 1994 Mar 3;253(3):275-81. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.